Gains in breast cancer drug seen
29th Dec 2005, 12:53 GMT
MILWAUKEE -- A second member of a new class of drugs has proved more effective than the gold standard, tamoxifen, at preventing breast cancer from recurring in women who received the medicine as initial therapy right after surgery.
Gains in breast cancer drug seen related news:
- New breast cancer drug 21 percent as effective as tamoxifen in preventing relapse — The Earth Times Online Newspaper
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Broader Novartis breast cancer drug use approved — Reuters: Business
- Novartis breast cancer drug use approved — Reuters: Business
- Broader Novartis breast cancer drug use approved (Reuters) — Yahoo! News: Business
- FDA OKs broader Novartis breast cancer drug use — KeralaNext: Business
- Breast cancer drug 'is better than tamoxifen' — Telegraph News | UK News
- Breast cancer drug approved for broader use — baltimoresun.com - nation/world
- Drug OK'd to Fight Breast Cancer Relapse (Associated Press) —
- FDA backs new use for breast cancer drug — Seattle Post-Intelligencer: Lifestyle
Latest news from Boston Globe -- National News:
- Lame-duck Congress faces many tasks
- President Ford sets record for longevity
- Hospitals join effort to give faster heart care
- Gallaudet seeks opinions on leader
- Lieberman won't rule out GOP caucusing
- 2 senators may enter '08 picture
- Catholic bishops turn to internal issues
- Victims of a New York crash are mourned
- Mall memorial to King reaches milestone
- Bishops call for change on Iraq policy